EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor

Sarah Dietz-Terjung iD, Svenja Straßburg, Christoph Schöbel, Tim Schulte, Paul Dietz, Fatma Ezzahra Gahbiche, Jose Ortiz, Christian Taube, Gerhard Weinreich, Sivagurunathan Sutharsan, Matthias Welsner

Sleep and Breathing · 2025

DOI: 10.1007/s11325-025-03451-8 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Sarah Dietz-Terjung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany. sarah.terjung@uk-essen.de. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quinolones, Aminophenols, Benzodioxoles. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cystic fibrosis (CF) is a life-limiting autosomal recessive disease often treated with triple CFTR modulator therapy (elexacaftor/tezacaftor/ivacaftor, ETI). Sleep disturbances are common in people with CF (pwCF). This study evaluated the Sleepiz One+, a non-contact radar-based biomotion sensor, for monitoring respiratory rate, heart rate, apnea-hypopnea index (AHI), and sleep quality in pwCF with ≥ 1 F508del allele during ETI therapy. The device’s suitability for home monitoring of therapy success was also assessed.

Methods

In a six-month observational study, 58 adult pwCF (2908 recordings) used the Sleepiz One + at home to collect longitudinal data on respiratory and sleep parameters during ETI therapy.

Results

Significant reductions in respiratory rate and time in bed were observed after starting ETI, with respiratory rate decreases detectable within 1–5 days. Short-term respiratory rate increases corresponded with infections verified by medical records. Heart rate decreased non-significantly, and sleep efficiency improved modestly. AHI slightly decreased overall but increased in some patients, possibly linked to ETI-related weight gain.

Conclusion

Sleepiz One + reliably tracked respiratory and sleep changes during ETI therapy in adult pwCF. It shows promise for early infection detection via respiratory rate monitoring, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuinolonesAminophenolsBenzodioxolesPolysomnographyPyrrolidinesIndolesPyridinesPyrazolesMonitoring, AmbulatoryHumansAdultMaleFemaleDrug CombinationsYoung AdultMiddle AgedAdolescentRespiratory RateHeart Rate

Stichwörter der Autor:innen

Cystic fibrosisETI therapyInfection detectionRespiratory rateSleep monitoringSleepiz one++

Substanzen

QuinolonesAminophenolsBenzodioxolesDrug CombinationsPyrrolidinesIndoleselexacaftorPyridinesPyrazolestezacaftor, ivacaftor drug combination

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany. sarah.terjung@uk-essen.de.
  • Center of interdisciplinary Telemedicine and TeleCare, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany. sarah.terjung@uk-essen.de.
  • Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.
  • Department of Sleep and Telemedicine, University Hospital Essen - Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.
  • Center of interdisciplinary Telemedicine and TeleCare, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

ORCID-Profile: Sarah Dietz-Terjung

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Dietz-Terjung, S., Straßburg, S., Schöbel, C., Schulte, T., Dietz, P., Gahbiche, F. E., Ortiz, J., Taube, C., Weinreich, G., Sutharsan, S., & Welsner, M. (2025). Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03451-8

Vancouver

Dietz-Terjung S, Straßburg S, Schöbel C, Schulte T, Dietz P, Gahbiche FE, et al. Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03451-8

BibTeX
@article{DietzTerjung2025,
  author = {Dietz-Terjung, Sarah and Straßburg, Svenja and Schöbel, Christoph and Schulte, Tim and Dietz, Paul and Gahbiche, Fatma Ezzahra and Ortiz, Jose and Taube, Christian and Weinreich, Gerhard and Sutharsan, Sivagurunathan and Welsner, Matthias},
  title = {Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor},
  journal = {Sleep and Breathing},
  year = {2025},
  doi = {10.1007/s11325-025-03451-8}
}
Kostenlos starten →